High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.

MLA

Li, Yan, et al. “High-Throughput Screening and Evaluation of Repurposed Drugs Targeting the SARS-CoV-2 Main Protease.” Signal Transduction and Targeted Therapy, vol. 6, no. 1, Sept. 2021, p. 356. EBSCOhost, https://doi.org/10.1038/s41392-021-00763-5.

APA

Li, Y., Zhang, J., Duan, Z., Wang, N., Sun, X., Zhang, Y., Fu, L., Liu, K., Yang, Y., Pan, S., Shi, Y., Zeng, H., Guo, G., Lai, R., & Zou, Q. (2021). High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease. Signal Transduction and Targeted Therapy, 6(1), 356. https://doi.org/10.1038/s41392-021-00763-5

Chicago

Li, Yan, Jinyong Zhang, Zilei Duan, Ning Wang, Xiangcheng Sun, Yanjing Zhang, Li Fu, et al. 2021. “High-Throughput Screening and Evaluation of Repurposed Drugs Targeting the SARS-CoV-2 Main Protease.” Signal Transduction and Targeted Therapy 6 (1): 356. doi:10.1038/s41392-021-00763-5.